VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 14, 2026
Stock Comparison
Agilent Technologies, Inc. vs AbbVie Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Agilent Technologies, Inc.
A · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Agilent Technologies, Inc.'s moat claims, evidence, and risks.
View A analysisAbbVie Inc.
ABBV · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AbbVie Inc.'s moat claims, evidence, and risks.
View ABBV analysisComparison highlights
- Moat score: both at 65 / 100.
- Segment focus: Agilent Technologies, Inc. has 3 segments (41.9% in Agilent CrossLab); AbbVie Inc. has 6 segments (47.4% in Immunology).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Agilent Technologies, Inc. has 5 moat types across 2 domains; AbbVie Inc. has 3 across 2.
Primary market context
Agilent Technologies, Inc.
Agilent CrossLab
Laboratory services, compliance/maintenance, consumables and lab informatics across the lab workflow
Global
B2B (installed base labs across pharma, diagnostics, academia and applied markets)
Aftermarket services + consumables + informatics
41.9%
AbbVie Inc.
Immunology
Immunology therapies for autoimmune diseases (biologics and small molecules; e.g., IL-23, JAK, TNF)
Global
Prescribing specialists (rheumatology, dermatology, gastroenterology), payers (PBMs/insurers), patients
Innovator biopharma (R&D, clinical development, regulated manufacturing, commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
Agilent Technologies, Inc. strengths
AbbVie Inc. strengths
Segment mix
Agilent Technologies, Inc. segments
Full profile >Life Sciences and Diagnostics Markets
Oligopoly
Agilent CrossLab
Competitive
Applied Markets
Oligopoly
AbbVie Inc. segments
Full profile >Immunology
Oligopoly
Oncology
Competitive
Neuroscience
Competitive
Aesthetics
Oligopoly
Eye Care
Competitive
Other Key Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.